Mechanism of internalization of the cytolethal distending toxin of Actinobacillus actinomycetemcomitans

Microbiology

Volumn 151, Issue 5, 2005, Pages 1395-1402

  Akifusa, Sumio ^a   Heywood, Wendy ^a   Nair, Sean P ^a   Stenbeck, Gudrun ^b   Henderson, Brian ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; BREFELDIN A; CYTOLETHAL DISTENDING TOXIN; MONENSIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ARTICLE; CELL CYCLE; CELL SURFACE; CELL TRANSPORT; COMPLEX FORMATION; CONTROLLED STUDY; ENDOSOME; EPITHELIUM CELL; EXPOSURE; HOST CELL; HUMAN; HUMAN CELL; METHODOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PURIFICATION;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; BACTERIAL TOXINS; BREFELDIN A; CELL CYCLE; CELL LINE; CELL MEMBRANE; ENDOSOMES; HUMANS; MONENSIN; RECOMBINANT PROTEINS;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; BACTERIA (MICROORGANISMS);

EID: 19044380605     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/mic.0.27671-0     Document Type: Article

References (46)

1. Akifusa, S., Poole, S., Lewthwaite, J., Henderson, B. & Nair, S. P. (2001). Recombinant Actinobacillus actinomycetemcomitans cytolethal distending toxin proteins are required to interact to inhibit human cell cycle progression and to stimulate human leukocyte cytokine synthesis. Infect Immun 69, 5925-5930.
2. Belibasakis, G., Johansson, A., Wang, Y., Claesson, R., Chen, C., Asikainen, S. & Kalfas, S. (2002). Inhibited proliferation of human periodontal ligament cells and gingival fibroblasts by Actinobacillus actinomycetemcomitans: involvement of the cytolethal distending toxin. Eur J Oral Sci 110, 366-373.
3. 2/M transition by preventing cdc2 protein kinase dephosphorylation and activation. Infect Immun 65, 5088-5095.
4. Cope, L. D., Lumbley, S., Latimer, J. L. & 8 other authors (1997). A diffusible cytotoxin of Haemophilus ducreyi. Proc Natl Acad Sci U S A 94, 4056-4061.
5. 2 phase. J Clin Invest 103, 107-115.
6. Cortes-Bratti, X., Chaves-Olarte, E., Lagergard, T. & Thelestam, M. (2000). Cellular internalization of cytolethal distending toxin from Haemophilus ducreyi. Infect Immun 68, 6903-6911.
7. Cortes-Bratti, X., Karlsson, C., Lagergard, T., Thelestam, M. & Frisan, T. (2001). The Haemophilus ducreyi cytolethal distending toxin induces cell cycle arrest and apoptosis via the DNA damage checkpoint pathways. J Biol Chem 276, 5296-5302.
8. Deng, K., Latimer, J. L., Lewis, D. A. & Hansen, E. J. (2001). Investigation of the interaction among the components of the cytolethal distending toxin of Haemophilus ducreyi. Biochem Biophys Res Commun 285, 609-615.
9. Dinter, A. & Berger, E. G. (1998). Golgi-disturbing agents. Histochem Cell Biol 109, 571-590.
10. Elwell, C. A. & Dreyfus, L. A. (2000). DNase I homologous residues in CdtB are critical for cytolethal distending toxin-mediated cell cycle arrest. Mol Microbiol 37, 952-963.
11. Falnes, P. O. & Sandvig, K. (2000). Penetration of protein toxins into cells. Curr Opin Cell Biol 12, 407-413.
12. Frisan, T., Cortes-Bratti, X., Chaves-Olarte, E., Stenerlow, B. & Thelestam, M. (2003). The Haemophilus ducreyi cytolethal distending toxin induces DNA double-strand breaks and promotes ATM-dependent activation of RhoA. Cell Microbiol 5, 695-707.
13. Ghrayeb, J., Kimura, H., Takahara, M., Hsiung, H. Masui, Y. & Inoue, M. (1984). Secretion cloning vectors in Escherichia coli. EMBO J 3, 2437-2442.
14. Haghjoo, E. & Galan, J. E. (2004). Salmonella typhi encodes a functional cytolethal distending toxin that is delivered into host cells by a bacterial-internalization pathway. Proc Natl Acad Sci U S A 101, 4614-4619.
15. Hassane, D. C., Lee, R. B. & Pickett, C. L. (2003). Campylobacter jejuni cytolethat distending toxin promotes DNA repair responses in normal human cells. Infect Immun 71, 541-545.
16. Henderson, B., Wilson, M. & Hyams, J. (1998). Cellular microbiology: cycling into the millennium. Trends Cell Biol 8, 384-387.
17. Henderson, B., Tabona, P., Poole, S. & Nair, S. P. (2001). Cloning and expression of the Actinobacillus actinomycetemcomitans thioredoxin (trx) gene and assessment of cytokine inhibitory activity. Infect Immun 69, 154-158.
18. Henderson, B., Ward, J. M., Nair, S. P. & Wilson, M. (2003). Molecular pathogenicity of the oral opportunistic pathogen Actinobacillus actinomycetemcomitans. Annu Rev Microbiol 57, 29-55.
19. Klausner, R. D., Donaldson, J. G. & Lippincott-Schwartz, J. (1992). Brefeldin A: insights into the control of membrane traffic and organelle structure. J Cell Biol 116, 1071-1080.
20. Lara-Tejero, M. & Galan, J. E. (2000). A bacterial toxin that controls cell cycle progression as a deoxyribonuclease I-like protein. Science 290, 354-357.
21. Lee, R. B. Hassane, D. C., Cottle, D. L. & Pickett, C. L. (2003). Interactions of Campylobacter jejuni cytolethal distending toxin sub-units CdtA and CdtC with HeLa cells. Infect Immun 71, 4883-4890.
22. Lewis, D. A., Stevens, M. K., Latimer, J. L., Ward, C. K., Deng, K., Blick, R., Lumbley, S. R., Ison, C. A. & Hansen, E. J. (2001). Characterization of Haemophilus ducreyi cdtA, cdtB, and cdtC mutants in in vitro and in vivo systems. Infect Immun 69, 5626-5634.
23. Mao, X. & DiRienzo, J. M. (2002). Functional studies of the recombinant subunits of a cytolethal distending holotoxin. Cell Microbiol 4, 245-255.
24. Mayer, M. P., Bueno, L. C., Hansen, E. J. & DiRienzo, J. M. (1999). Identification of a cytolethal distending toxin gene locus and features of a virulence-associated region in Actinobacillus actinomycetemcomitans. Infect Immun 67, 1227-1237.
25. McSweeney, L. A. & Dreyfus, L. A. (2004). Nuclear localization of the Escherichia coli cytolethal distending toxin CdtB subunit. Cell Microbiol 6, 447-458.
26. Nesic, D., Hsu, Y. & Stebbins, C. E. (2004). Assembly and function of a bacterial genotoxin. Nature 429, 429-433.
27. Nishikubo, S., Ohara, M., Ueno, Y., Ikura, M., Kurihara, H., Komatsuzawa, H., Oswald, E. & Sugai, M. (2003). An N-terminal segment of the active component of the bacterial genotoxin cytolethal distending toxin B (CDTB) directs CDTB into the nucleus. J Biol Chem 278, 50671-50681.
28. Ohara, M., Hayashi, T., Kusunoki, Y., Miyauchi, M., Takata, T. & Sugai, M. (2004). Caspase-2 and caspase-7 are involved in cytolethal distending toxin-induced apoptosis in Jurkat and MOLT-4 T-cell lines. Infect Immun 72, 871-879.
29. Okuda, J., Fukumoto, M., Takeda, Y. & Nishibuchi, M. (1997). Examination of diarrheagenicity of cytolethal distending toxin: suckling mouse response to the products of the cdtABC genes of Shigella dysenteriae. Infect Immun 65, 428-433.
30. Parkhill, J., Dougan, G., James, K. D. & 38 other authors (2001). Complete genome sequence of a multiple drug resistant Salmonella enterica serovar Typhi CT18. Nature 413, 848-852.
31. Pickett, C. L. & Whitehouse, C. A. (1999). The cytolethal distending toxin family. Trends Microbiol 7, 292-297.
32. Pickett, C. L., Pesci, E. C., Cottle, D. L., Russell, G., Erdem, A. N. & Zeytin, H. (1996). Prevalence of cytolethal distending toxin production in Campylobacter jejuni and relatedness of Campylobacter sp. cdtB gene. Infect Immun 64, 2070-2078.
33. Sato, T., Koseki, T., Yamato, K., Saiki, K., Konishi, K., Yoshikawa, M., Ishikawa, I. & Nishihara, T. (2002). p53-independent expression of p21(CIP1/WAF1) in plasmacytic cells during G(2) cell cycle arrest induced by Actinobacillus actinomycetemcomitans cytolethal distending toxin. Infect Immun 70, 528-534.
34. Scott, D. A. & Kaper, J. B. (1994). Cloning and sequencing of the genes encoding Escherichia coli cytolethal distending toxin. Infect Immun 62, 244-251.
35. Shenker, B. J. (1987). Immunologic dysfunction in the pathogenesis of periodontal diseases. J Clin Periodontol 14, 489-498.
36. Shenker, B. J., McKay, T., Datar, S., Miller, M., Chowhan, R. & Demuth, D. (1999). Actinobacillus actinomycetemcomitans immunosuppressive protein is a member of the family of cytolethal distending toxins capable of causing a G2 arrest in human T cells. J Immunol 162, 4773-4780.
37. Shenker, B. J., Besack, D., McKay, T., Pankoski, L., Zekavat, A. & Demuth, D. R. (2004). Actinobacillus actinomycetemcomitans cytolethal distending toxin (Cdt): evidence that the holotoxin is composed of three subunits: CdtA, CdtB, and CdtC. J Immunol 172, 410-417.
38. Slots, J. & Ting, M. (1999). Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in human periodontal disease: occurrence and treatment. Periodontol 2000 20, 82-121.
39. Sugai, M., Kawamoto, T., Peres, S. Y., Ueno, Y., Komatsuzawa, H., Fujiwara, T., Kurihara, H., Suginaka, H. & Oswald, E. (1998). The cell cycle-specific growth-inhibitory factor produced by Actinobacillus actinomycetemcomitans is a cytolethal distending toxin. Infect Immun 66, 5008-5019.
40. Takemura, S., Asano, R., Tsumoto, K. & 10 other authors (2000). Construction of a diabody (small recombinant bispecific antibody) using a refolding system. Protein Eng 13, 583-588.
41. Tartakoff, A. M. (1983). Perturbation of vesicular traffic with the carboxylic ionophore monensin. Cell 32, 1026-1028.
42. Van Winkelhoff, A. J. & Slots, J. (1999). Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in nonoral infections. Periodontol 2000 20, 122-135.
43. Whitehouse, C. A., Balbo, P. B., Pesci, E. C., Cottle, D. L., Mirabito, P. M. & Pickett, C. L. (1999). Campylobacter jejuni cytolethal distending toxin causes a G2-phase cell cycle block. Infect Immun 66, 1934-1940.
44. Wilson, M. & Henderson, B. (1995). Virulence factors of Actinobacillus actinomycetemcomitans relevant to the pathogenesis of inflammatory periodontal diseases. FEMS Microbiol Rev 17, 365-379.
45. Yamamoto, K., Tominaga, K., Sukedai, M., Okinaga, T., Iwanaga, K., Nishihara, T. & Fukuda, J. (2004). Delivery of cytolethal distending toxin B induces cell cycle arrest and apoptosis in gingival squamous cell carcinoma in vitro. Eur J Oral Sci 112, 445-451.
46. Young, V. B., Knox, K. A. & Schauer, D. B. (2000). Cytolethal distending toxin sequence and activity in the enterohepatic pathogen Helicobacter hepaticus. Infect Immun 68, 184-191.